Melanoma: Updates from Brisbane, Australia
PROGRAM DESCRIPTION Roxana S. Dronca, MD, and Lisa A. Kottschade, APRN, MSN, CNP, offer their expert insights into recent data on advanced melanoma presented at a joint meeting of the ...
PROGRAM DESCRIPTION
Roxana S. Dronca, MD, and Lisa A. Kottschade, APRN, MSN, CNP, offer their expert insights into recent data on advanced melanoma presented at a joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma Research in Brisbane, Australia. Listen to what these experts have to say about combination therapy in the adjuvant setting for metastatic melanoma, real-world utilization of checkpoint inhibitor therapy, sequencing options for BRAF +/- MEK Inhibition following immunotherapy, and the management of rheumatological immune-related adverse events following treatment with checkpoint inhibitors.
EDUCATIONAL OBJECTIVES
At the conclusion of this activity, participants should be better able to:Review the latest data on advanced/metastatic melanomaDiscuss how therapeutic developments in advanced/metastatic melanoma are guiding research into improved care
Read more about this
Write the first review
Join now
to leave a review or read peer reviews!
Resource tags
Show all tags